The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world adherence and treatment discontinuation with trifluridine/tipiracil (FTD-TPI) compared with regorafenib (REG) for the treatment of metastatic colorectal cancer (mCRC).
 
Anuj K. Patel
No Relationships to Disclose
 
Mei Sheng Duh
Research Funding - Bayer; GlaxoSmithKline; Janssen; Pfizer; Sanofi; Taiho Pharmaceutical
Expert Testimony - Abbvie
 
Victoria E. Barghout
Employment - VEB Healthcare
Honoraria - Lilly; Taiho Pharmaceutical
Consulting or Advisory Role - Eisai; Novartis Pharmaceuticals UK Ltd.; Taiho Pharmaceutical
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly; Taiho Pharmaceutical
 
Mihran Ara Yenikomshian
Research Funding - Braintree Laboratories (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Yongling Xiao
Research Funding - Abbvie (Inst); Janssen (Inst); Medtronic (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Willy Wynant
Research Funding - Taiho Pharmaceutical (Inst)
 
Majid Tabesh
Consulting or Advisory Role - Taiho Pharmaceutical
 
Charles S. Fuchs
Consulting or Advisory Role - Agios; Bayer; Dicerna; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; KEW; Lilly; Merck; Merrimack; Sanofi; Taiho Pharmaceutical